NCT06148246 is a NA clinical trial of Family Fit Condition in Weight Gain Prevention, sponsored by University of Florida.

Who is sponsoring NCT06148246?

NCT06148246 is sponsored by University of Florida.

What drugs are being tested in NCT06148246?

Interventions in NCT06148246: Family Fit Condition.

What condition does NCT06148246 study?

NCT06148246 studies Weight Gain Prevention, Physical Inactivity.

Is NCT06148246 still recruiting?

NCT06148246 is currently completed. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT06148246

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Family Fit Iterative App Development

Completed NA Last updated 9 March 2026

What this trial tests

NA trial testing Family Fit Condition in Weight Gain Prevention in 30 participants. Completed in 16 July 2025.

Timeline

18 January 2024

Primary endpoint
6 July 2025

16 July 2025

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	30
Start date	18 January 2024
Primary completion	6 July 2025
Estimated completion	16 July 2025
Sites	1 location across United States

Drugs / interventions tested

Family Fit Condition

Conditions studied

Weight Gain Prevention — all drugs for Weight Gain Prevention →
Physical Inactivity — all drugs for Physical Inactivity →

Sponsor

University of Florida

Who can join

Adults 9 to 65, any sex, with Weight Gain Prevention or Physical Inactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this study is to test the acceptability and usability of a mobile application (app) for family-based physical activity and weight gain prevention among parent/guardian and child (ages 9-12 years) dyads.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06148246 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06148246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing